Davis Polk advised BiondVax Pharmaceuticals Ltd. in the offering. BiondVax Pharmaceuticals Ltd. closed its registered at-the-market offering of shares of its American depositary shares for up…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
